ATF2 and esophageal cancer: MiR-26a inhibits esophageal cancer progression; Mi et al. [76] found that TAMs-derived exosomes in esophageal cancer overexpressed the lncRNA AFAP1-AS1, targeting the miR-26a/ATF2 pathway and promoting the proliferation and metastasis of esophageal cancer cells.